(Photo by: Shutterstock/Katherine Welles)

Humana, Quantified Ventures, and Volunteers of America Partner to Establish First of Its Kind Health Outcomes Fund

Originally published on 

The new fund will help Volunteers of America sustainably scale Family Focused Recovery program operations to provide comprehensive services to mothers with substance use disorder and their children

Humana Inc. (NYSE: HUM) today re-confirms its commitment to provide innovative models of care for families through a catalytic investment of $5 million in an outcomes-based fund, supported by Quantified Ventures; the new fund will help Volunteers of America (VOA) sustainably scale Family Focused Recovery (FFR) program operations to provide comprehensive services to mothers with substance use disorder and their children.

This press release features multimedia. View the full release here: new window

Nearly 20 million adult Americans struggle with a substance use disorder, and women account for more than 30 percent of the nearly 50,000 opioid-related overdose deaths in 2018. The FFR programs operated by VOA are among the few in the U.S. that combine intensive addiction treatment services with wrap around family support to address underlying social determinants of health that often impede recovery.

“We know both mothers and children thrive if they remain together during treatment and the needs of all family members are being met. Healthy babies and healthy moms in recovery are our goals,” said VOA National President Mike King. “Thanks to this innovative partnership, we will be able to offer this successful model of recovery to many more families in need.”

In partnership with Quantified Ventures, Humana is providing Volunteers of America affiliates with access to capacity-building services and innovative, outcomes-based financing to help VOA scale to meet increasing demand in the communities they serve.

As part of its Bold Goal population health strategy, Humana has committed to the development and scaling of key community programs that can improve both clinical and social health outcomes among its members and their families. With an initial focus on FFR, Humana and Quantified Ventures are committed to working with community-based organizations (CBOs) to bring innovative financing solutions to strengthen our social safety net for vulnerable populations. This includes direct investment, the development of value-based contracting arrangements, and the structuring of robust, accountable, and sustained financing arrangements that deliver the capital needed to address critical population health challenges in priority Humana markets.

“This is the time for smart, bold solutions that strengthen our social safety net. With strong partners like Volunteers of America and Quantified Ventures, we’re able to extend our impact into the communities we serve, better enabling us to address the holistic needs of our members and their families,” said Dr. Will Shrank, Humana’s Chief Medical & Government Affairs Officer.

COVID-19 has severely strained a social safety net that already struggled to meet demand. It also has revealed the financial vulnerability of many CBOs, which often operate on razor-thin margins and rely on support from a patchwork of grants, donations, and government contracts that rarely cover actual program costs. This lack of adequate and flexible capital impedes service expansion and long-term sustainability. By expanding VOA’s capacity to engage in value-based purchasing arrangements and achieve consistent revenue streams, Humana and Quantified Ventures will support FFR program stability, planning, and growth.

“Humana is boldly stepping in to engage as a sustainability partner to CBOs that – now more than ever – are critical to restoring wellbeing and health in their communities. This is exactly the type of corporate leadership and flexible capital our communities need right now to solve big challenges,” said Eric Letsinger, CEO of Quantified Ventures. “We are thrilled to be deepening our partnership with Humana and look forward to continuing our work with innovative CBOs like Volunteers of America.”

In partnership, Humana and Quantified Ventures will:

  • Create a dedicated FFR Fund, a first-of-its-kind vehicle designed to deliver high-impact health outcomes for pregnant mothers in priority states. This fund is designed to encourage further investment to drive towards scale.
  • Structure payment models between Humana and partner CBOs that enable efficient and predictable scaling of priority community-based programs, starting with FFR.
  • Generate model programs and outcomes data to inform policies that seek to shift the balance of medical spending toward human services that address social determinants of health to improve population health and wellbeing.
  • Deliver meaningful improvements in health and wellbeing to the thousands of individuals receiving services to combat substance use disorder and other health-related social needs.



Latest News

invisible disability, self

Overcoming Stigma: How to Increase Self-Identification of Invisible Disabilities

The International Day of Persons With Disabilities is aimed at raising awareness of disability issues, empowering people with disabilities and advocating for a more disability-inclusive world. While visible disabilities like mobility issues or Down syndrome are immediately apparent, there are also medical conditions that affect a person’s daily functioning but are…


Humana CEO Bruce Broussard Named Businessperson of the Year

Originally posted on Humana LinkedIn. Humana ranked No. 25 for The DiversityInc Top 50 Companies for Diversity list in 2020. We’d like to congratulate CEO Bruce Broussard on being named one of Fortune‘s 2020 Businesspersons of the Year. “Since being named CEO of the health insurer in 2013, Broussard has continued Humana’s push into…

Child studying to improve test scores

Test Scores Drop Dramatically for Black, Hispanic and Poor Children Due to COVID-19; Nasdaq Moves to Require Diversity for Listed Companies; and More

Math and reading test scores have dropped dramatically for Black, Hispanic and poor children due to COVID-19, new study warns. Results of lockdowns, home-schooling, and Zoom classrooms as a result of COVID-19 are starting to come in, and the numbers aren’t good. According to a review of more than 4…


The Platinum Plan: How Trump Increased His Black Vote by 50% and What We Can Learn From It

Do you know what Donald Trump’s “Platinum Plan” was? Most Black people I know do. Most white people have never heard of it. The plan — a two-page document released just weeks before the 2020 election — details the four pillars of Trump’s commitment to Black Americans (Opportunity, Security, Prosperity…

HIV, AIDS, Misconception

Fact Check: Misconceptions About HIV/AIDS

Similar to the coronavirus and the ongoing COVID-19 pandemic throughout 2020, many of the misconceptions and stigma surrounding HIV and AIDS have been fueled by fear. Although information surrounding the disease is more accessible now that we’re months into the pandemic, many people still misunderstand the condition, the treatment options,…

President-elect Joe Biden with senior adviser Symone Sanders

Biden and Harris Announce All-Female White House Communications Team; After 9 Long Months, COVID-19 Hits New Peak; and More

Biden and Harris announce entirely female-led White House communications team. President-elect Joe Biden’s transition to the White House continues at a brisk pace. On Monday, Nov. 30th, Biden and Vice President-elect Kamala Harris received their first daily Presidential intelligence briefings. A day earlier, CBS News has reported that the pair…

BASF Introduces Neutrol® MGDA, a Readily Biodegradable Complexing Agent for Personal Care Applications

Originally published on BASF ranked No. 14 on The Diversityinc Top 50 Companies for Diversity list in 2020. Highly stable over a wide pH range Eco-friendly and easy to formulate With Neutrol® MGDA, BASF’s Care Creations® is launching a highly stable, eco-friendly complexing agent (also called: chelating agent) for personal care applications….

Abbott Launches the First Infant Formula in Canada with an Ingredient Identical in Structure to Immune Component Found in Breast Milk

Originally published on Abbott ranked No. 8 on The DiversityInc Top 50 Companies for Diversity list in 2020. 2′-Fucosyllactose Oligosaccharide†(2′-FL†) is now available in Abbott’s infant formula, Similac Pro-Advance® HMOs, like 2′-FL, in breast milk help support a baby’s immune system [1] HMOs, like 2′-FL, feed good bacteria in the…